DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo


257.45 -0.57 (-0.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PCYC $257.45 -0.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $257.95
Previous Close $258.02
Daily Range $256.91 - $258.61
52-Week Range $82.51 - $260.47
Market Cap $19.8B
P/E Ratio 234.56
Dividend (Yield) $0.00 (0.0%)
Volume 3,096,156
Average Daily Volume 1,726,492
Current FY EPS $0.26




Drug Makers


A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website:

News & Commentary

Johnson & Johnson's Earnings: What You Need to Know

Here’s what Johnson & Johnson’s quarterly earnings call means to investors like you.

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern

7 Trends Drug Investors Should Know

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Mylan Proposes to Acquire Perrigo, Sets Both Stocks Soaring - Analyst Blog

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?

AbbVie is reportedly still interested in acquiring additional assets to help it over the Humira patent cliff hump. Would Acadia Pharmaceuticals be a good match for this big pharma?

LinkedIn Among New Buys Of Top Rated Funds

16 Biotech Catalysts SunTrust Is Tracking

See More PCYC News...

PCYC's Top Competitors

PCYC $257.45 (-0.22%)
Current stock: PCYC
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB